Marksans Pharma

MARKSANS30 Apr 2024
Pharmaceuticals
₹
-3.35 (-1.98%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Marksans Pharma
Marksans Pharma
Pharmaceuticals
MARKSANS30 Apr 2024
₹
-3.35 (-1.98%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Marksans Pharma - Share Price & Details

Lowest Today
165.05
Highest Today
170.2
Today’s Open
170
Prev. Close
169.15
52 Week High
185.5
52 Week Low
70.55
Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
103.69%
Upper Circuit
Lower Circuit
P/E TTM
63.28
P/B Ratio
6.46
Traded Value(Cr)
0.00
EPS TTM
2.62
Book value
Dividend
0.30%

Price Performance

-2.36 %
1 Wk
4.94 %
1 M
12.79 %
3 M
103.69 %
1 Y
3.21 %
YTD

Traded Volume Movement

Technical Details

Support 3
159
Support 2
162
Support 1
164
Pivot Point :
168
Resistance 1
169
Resistance 2
173
Resistance 3
175

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Marksans Pharma Ltd
₹165.80(-3.35/-1.98%)
165.80-3.357,513.45103.6963.286.46
Lupin Ltd
₹1,645.90(+8.45/0.52%)
1,645.90+8.4575,011.91132.2136.393.89
Ipca Laboratories Ltd
₹1,339.50(+5.50/0.41%)
1,339.50+5.5033,983.6889.1061.695.47
J B Chemicals & Pharmaceuticals Ltd
₹1,905.25(-1.40/-0.07%)
1,905.25-1.4029,568.4983.2058.3711.01
Sanofi India Ltd
₹8,325.55(+48.05/0.58%)
8,325.55+48.0519,173.7453.4132.4618.88
IOL Chemicals & Pharmaceuticals Ltd
₹393.70(-2.80/-0.71%)
393.70-2.802,311.24-3.8713.461.46

About Marksans Pharma Ltd

Marksans Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 7513.45 crores. It has reported a sales of Rs. 241.36 crores and a net profit of Rs. 25.29 crores for the quarter ended December 2018. The company management includes Mark Saldanha, Mark Saldanha,Harshavardhan Panigrahi,Seetharama Raju Buddharaju,Sandra Saldanha,Digant Mahesh Parikh,Varddhman Vikramaditya Jain,Abhinna Sundar Mohanty,Sunny Sharma,Shailaja Vardhan (Marksans Pharma Ltd) among others.
Chairman
Mark Saldanha
Registered office
11th Flr GRANDEUR Oshiwara,Veera Desai Extn Rd Andheri(W),Mumbai,Maharashtra,400053
FAX :91-22-40012011
Background
Incorporation Year1992
Face Value₹1
Market Lot1

Latest News

Share market in April!
Share market in April: Indian stock market benchmarks, the Nifty 50 and the Sensex extended their gains into the third consecutive month in April, rising over a per cent each. Midcap and Smallcap indices saw robust gains last month. The BSE Midcap index rose 7 per cent while the BSE Smallcap index jumped 10 per cent in April. Sensex hit its fresh record high of 75,124.28 on April 9.
01 May 2024 | 11:56 AM
General Elections 2024: Will Nifty50 extend gains for 4th month in May?
With the general elections 2024 ongoing and the hopes of the incumbent PM Modi retaining office for the third term, Indian markets are likely to extend gains, giving positive returns for the fourth straight month in May. Moreover, improved macro data, continued foreign investor inflows, decent March quarter earnings and overall positive global trends will also aid investor sentiment this month.
01 May 2024 | 11:10 AM
Share market in April!
Share market in April: Indian stock market benchmarks, the Nifty 50 and the Sensex extended their gains into the third consecutive month in April, rising over a per cent each. Midcap and Smallcap indices saw robust gains last month. The BSE Midcap index rose 7 per cent while the BSE Smallcap index jumped 10 per cent in April. Sensex hit its fresh record high of 75,124.28 on April 9.
01 May 2024 | 11:56 AM
Adani Wilmar Q4 results: Net profit up 59% to Rs 156 crore
Adani Wilmar on May 1 reported a 59 percent surge in net profit at Rs 156 crore for the quarter ended 31 March, 2024. The Gautam Adani company had posted a net profit of Rs 98 crore in the year-ago period.Adani Wilmar, a joint venture between Adani Enterprises and Wilmar International, sells edible oil variants, including mustard, sunflower and soyabean.
01 May 2024 | 03:14 PM
IFCI turns a corner with advisory biz; posts first profit in 7 years
Government-owned non-bank IFCI Ltd has finally turned the corner in the 2023-24 financial year, reporting a profit after seven consecutive years of losses following its expansion into government and private corporate advisory services.The company swung to a profit of  ₹128 crore for FY24 from a loss of  ₹288 crore in the year before. Standalone revenue improved 19% to  ₹896 crore.
01 May 2024 | 03:00 PM
view more news

How to buy Marksans Pharma shares on nse?

To buy Marksans Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Marksans Pharma share price today?

The Marksans Pharma shares price on nse is Rs.165.8 today.

What is the market cap of Marksans Pharma shares on NSE ?

The company has a market capitalization of Rs.7513.45Cr

What is the PE & PB ratio of Marksans Pharma shares ?

PE is 63.28 and PB is 6.46

What is the 52 Week High and Low of Marksans Pharma shares?

Marksans Pharma stock price high: Rs.185.5 Marksans Pharma stock price low: Rs.70.55
BUY
SELL